Key result
Chemotherapy resolves severe secondary lipoprotein abnormalities and acute-phase response in B-cell lymphoma.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Lipoprotein abnormalities seen in patients with inflammatory diseases are thought to develop secondary to circulating cytokines and the accompanying acute-phase response. Patient's with lymphoma may develop similar lipoprotein abnormalities but the mechanism is unclear. We report a patient with B-cell lymphoma who presented with an HDL cholesterol level of 3 mg dl-1, an ApoA level of 17.4 mg dl-1, elevated triglyceride level (272 mg dl-1) and an elevated ApoB level of 156 mg dl-1. Density gradient analysis of the patient's lipoproteins demonstrated a virtual absence of an identifiable HDL particle. Serum amyloid A and C-reactive protein were also elevated. All of the lipoprotein abnormalities resolved with chemotherapy and resolution of the acute-phase response. The acute-phase response may be associated with striking lipoprotein abnormalities in a subset of patients with lymphoma. Lymphoma should be included in the differential diagnosis of patients with hypertriglyceridaemia and low HDL cholesterol.
No takes yet. Share an insight, caveat, or question.
Blackman et al. (1993) conducted a case report in B-cell lymphoma with acute-phase response and lipoprotein abnormalities (n=1). Chemotherapy was evaluated on Resolution of lipoprotein abnormalities and acute-phase response. Chemotherapy resolved severe lipoprotein abnormalities (HDL 3 mg/dl, triglycerides 272 mg/dl, ApoA 17.4 mg/dl, ApoB 156 mg/dl) alongside the acute-phase response in a patient with B-cell lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: